Cargando…
Clinical evaluation of automated quantitative MRI reports for assessment of hippocampal sclerosis
OBJECTIVES: Hippocampal sclerosis (HS) is a common cause of temporal lobe epilepsy. Neuroradiological practice relies on visual assessment, but quantification of HS imaging biomarkers—hippocampal volume loss and T2 elevation—could improve detection. We tested whether quantitative measures, contextua...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755617/ https://www.ncbi.nlm.nih.gov/pubmed/32749588 http://dx.doi.org/10.1007/s00330-020-07075-2 |
_version_ | 1783626386263506944 |
---|---|
author | Goodkin, Olivia Pemberton, Hugh G. Vos, Sjoerd B. Prados, Ferran Das, Ravi K. Moggridge, James De Blasi, Bianca Bartlett, Philippa Williams, Elaine Campion, Thomas Haider, Lukas Pearce, Kirsten Bargallό, Nuria Sanchez, Esther Bisdas, Sotirios White, Mark Ourselin, Sebastien Winston, Gavin P. Duncan, John S. Cardoso, Jorge Thornton, John S. Yousry, Tarek A. Barkhof, Frederik |
author_facet | Goodkin, Olivia Pemberton, Hugh G. Vos, Sjoerd B. Prados, Ferran Das, Ravi K. Moggridge, James De Blasi, Bianca Bartlett, Philippa Williams, Elaine Campion, Thomas Haider, Lukas Pearce, Kirsten Bargallό, Nuria Sanchez, Esther Bisdas, Sotirios White, Mark Ourselin, Sebastien Winston, Gavin P. Duncan, John S. Cardoso, Jorge Thornton, John S. Yousry, Tarek A. Barkhof, Frederik |
author_sort | Goodkin, Olivia |
collection | PubMed |
description | OBJECTIVES: Hippocampal sclerosis (HS) is a common cause of temporal lobe epilepsy. Neuroradiological practice relies on visual assessment, but quantification of HS imaging biomarkers—hippocampal volume loss and T2 elevation—could improve detection. We tested whether quantitative measures, contextualised with normative data, improve rater accuracy and confidence. METHODS: Quantitative reports (QReports) were generated for 43 individuals with epilepsy (mean age ± SD 40.0 ± 14.8 years, 22 men; 15 histologically unilateral HS; 5 bilateral; 23 MR-negative). Normative data was generated from 111 healthy individuals (age 40.0 ± 12.8 years, 52 men). Nine raters with different experience (neuroradiologists, trainees, and image analysts) assessed subjects’ imaging with and without QReports. Raters assigned imaging normal, right, left, or bilateral HS. Confidence was rated on a 5-point scale. RESULTS: Correct designation (normal/abnormal) was high and showed further trend-level improvement with QReports, from 87.5 to 92.5% (p = 0.07, effect size d = 0.69). Largest magnitude improvement (84.5 to 93.8%) was for image analysts (d = 0.87). For bilateral HS, QReports significantly improved overall accuracy, from 74.4 to 91.1% (p = 0.042, d = 0.7). Agreement with the correct diagnosis (kappa) tended to increase from 0.74 (‘fair’) to 0.86 (‘excellent’) with the report (p = 0.06, d = 0.81). Confidence increased when correctly assessing scans with the QReport (p < 0.001, η(2)(p) = 0.945). CONCLUSIONS: QReports of HS imaging biomarkers can improve rater accuracy and confidence, particularly in challenging bilateral cases. Improvements were seen across all raters, with large effect sizes, greatest for image analysts. These findings may have positive implications for clinical radiology services and justify further validation in larger groups. KEY POINTS: • Quantification of imaging biomarkers for hippocampal sclerosis—volume loss and raised T2 signal—could improve clinical radiological detection in challenging cases. • Quantitative reports for individual patients, contextualised with normative reference data, improved diagnostic accuracy and confidence in a group of nine raters, in particular for bilateral HS cases. • We present a pre-use clinical validation of an automated imaging assessment tool to assist clinical radiology reporting of hippocampal sclerosis, which improves detection accuracy. |
format | Online Article Text |
id | pubmed-7755617 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-77556172020-12-28 Clinical evaluation of automated quantitative MRI reports for assessment of hippocampal sclerosis Goodkin, Olivia Pemberton, Hugh G. Vos, Sjoerd B. Prados, Ferran Das, Ravi K. Moggridge, James De Blasi, Bianca Bartlett, Philippa Williams, Elaine Campion, Thomas Haider, Lukas Pearce, Kirsten Bargallό, Nuria Sanchez, Esther Bisdas, Sotirios White, Mark Ourselin, Sebastien Winston, Gavin P. Duncan, John S. Cardoso, Jorge Thornton, John S. Yousry, Tarek A. Barkhof, Frederik Eur Radiol Neuro OBJECTIVES: Hippocampal sclerosis (HS) is a common cause of temporal lobe epilepsy. Neuroradiological practice relies on visual assessment, but quantification of HS imaging biomarkers—hippocampal volume loss and T2 elevation—could improve detection. We tested whether quantitative measures, contextualised with normative data, improve rater accuracy and confidence. METHODS: Quantitative reports (QReports) were generated for 43 individuals with epilepsy (mean age ± SD 40.0 ± 14.8 years, 22 men; 15 histologically unilateral HS; 5 bilateral; 23 MR-negative). Normative data was generated from 111 healthy individuals (age 40.0 ± 12.8 years, 52 men). Nine raters with different experience (neuroradiologists, trainees, and image analysts) assessed subjects’ imaging with and without QReports. Raters assigned imaging normal, right, left, or bilateral HS. Confidence was rated on a 5-point scale. RESULTS: Correct designation (normal/abnormal) was high and showed further trend-level improvement with QReports, from 87.5 to 92.5% (p = 0.07, effect size d = 0.69). Largest magnitude improvement (84.5 to 93.8%) was for image analysts (d = 0.87). For bilateral HS, QReports significantly improved overall accuracy, from 74.4 to 91.1% (p = 0.042, d = 0.7). Agreement with the correct diagnosis (kappa) tended to increase from 0.74 (‘fair’) to 0.86 (‘excellent’) with the report (p = 0.06, d = 0.81). Confidence increased when correctly assessing scans with the QReport (p < 0.001, η(2)(p) = 0.945). CONCLUSIONS: QReports of HS imaging biomarkers can improve rater accuracy and confidence, particularly in challenging bilateral cases. Improvements were seen across all raters, with large effect sizes, greatest for image analysts. These findings may have positive implications for clinical radiology services and justify further validation in larger groups. KEY POINTS: • Quantification of imaging biomarkers for hippocampal sclerosis—volume loss and raised T2 signal—could improve clinical radiological detection in challenging cases. • Quantitative reports for individual patients, contextualised with normative reference data, improved diagnostic accuracy and confidence in a group of nine raters, in particular for bilateral HS cases. • We present a pre-use clinical validation of an automated imaging assessment tool to assist clinical radiology reporting of hippocampal sclerosis, which improves detection accuracy. Springer Berlin Heidelberg 2020-08-04 2021 /pmc/articles/PMC7755617/ /pubmed/32749588 http://dx.doi.org/10.1007/s00330-020-07075-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Neuro Goodkin, Olivia Pemberton, Hugh G. Vos, Sjoerd B. Prados, Ferran Das, Ravi K. Moggridge, James De Blasi, Bianca Bartlett, Philippa Williams, Elaine Campion, Thomas Haider, Lukas Pearce, Kirsten Bargallό, Nuria Sanchez, Esther Bisdas, Sotirios White, Mark Ourselin, Sebastien Winston, Gavin P. Duncan, John S. Cardoso, Jorge Thornton, John S. Yousry, Tarek A. Barkhof, Frederik Clinical evaluation of automated quantitative MRI reports for assessment of hippocampal sclerosis |
title | Clinical evaluation of automated quantitative MRI reports for assessment of hippocampal sclerosis |
title_full | Clinical evaluation of automated quantitative MRI reports for assessment of hippocampal sclerosis |
title_fullStr | Clinical evaluation of automated quantitative MRI reports for assessment of hippocampal sclerosis |
title_full_unstemmed | Clinical evaluation of automated quantitative MRI reports for assessment of hippocampal sclerosis |
title_short | Clinical evaluation of automated quantitative MRI reports for assessment of hippocampal sclerosis |
title_sort | clinical evaluation of automated quantitative mri reports for assessment of hippocampal sclerosis |
topic | Neuro |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755617/ https://www.ncbi.nlm.nih.gov/pubmed/32749588 http://dx.doi.org/10.1007/s00330-020-07075-2 |
work_keys_str_mv | AT goodkinolivia clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT pembertonhughg clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT vossjoerdb clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT pradosferran clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT dasravik clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT moggridgejames clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT deblasibianca clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT bartlettphilippa clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT williamselaine clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT campionthomas clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT haiderlukas clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT pearcekirsten clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT bargallonuria clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT sanchezesther clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT bisdassotirios clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT whitemark clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT ourselinsebastien clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT winstongavinp clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT duncanjohns clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT cardosojorge clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT thorntonjohns clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT yousrytareka clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis AT barkhoffrederik clinicalevaluationofautomatedquantitativemrireportsforassessmentofhippocampalsclerosis |